Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury

Traumatic brain injury (TBI) is a neurodegenerative disorder for which no effective pharmacological treatment is available. Glucagon-like peptide 1 (GLP-1) analogues such as Exenatide have previously demonstrated neuro-trophic and neuroprotective effects in cellular and animal models of TBI. However...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurobiol Dis
Main Authors: Bader, Miaad, Li, Yazhou, Lecca, Daniela, Rubovitch, Vardit, Tweedie, David, Glotfelty, Elliot, Rachmany, Lital, Kim, Hee Kyung, Choi, Ho-Il, Hoffer, Barry J., Pick, Chaim G., Greig, Nigel H., Kim, Dong Seok
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6710831/
https://ncbi.nlm.nih.gov/pubmed/30471415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2018.11.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados